Schott Pharma
Manufactures drug containment and delivery systems for injectable drugs.
1SXP | F
Overview
Corporate Details
- ISIN(s):
- DE000A3ENQ51
- LEI:
- 529900TU48UE99NHEY88
- Country:
- Germany
- Address:
- Hattenbergstraße 10, 55122 Mainz
- Website:
- https://www.schott-pharma.com/en
- Sector:
- Manufacturing
Description
Schott Pharma is a developer and manufacturer of drug containment solutions and delivery systems for injectable drugs. Serving the pharmaceutical and biotech industries, its portfolio includes prefillable syringes, cartridges, vials, and ampoules. The company provides scientifically proven products designed for the safe storage and administration of medications. Beyond individual components, Schott Pharma offers complete, compatible systems and a range of services, including analytical, development, fill-and-finish, and regulatory support. This integrated approach supports clients from clinical trials through to commercialization, ensuring compatibility across the entire pharma value chain.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-19 15:05 |
SCHOTT Pharma AG & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlun…
|
German | 90.9 KB | ||
| 2025-12-18 12:26 |
SCHOTT Pharma AG & Co. KGaA: Reinhard Mayer, buy
|
English | 6.3 KB | ||
| 2025-12-16 00:00 |
2025 December Updated Declarations of Conformity (German)
|
German | 122.0 KB | ||
| 2025-12-11 07:00 |
SCHOTT Pharma delivers on full-year revenue and profitability targets
|
English | 39.9 KB | ||
| 2025-12-11 00:00 |
Remunerations report 2025
|
English | 534.2 KB | ||
| 2025-12-11 00:00 |
Sustainability Report 2025
|
English | 53.9 MB | ||
| 2025-12-11 00:00 |
Financial Statement of SCHOTT Pharma AG & Co. KGaA (HGB) 2025
|
English | 833.1 KB | ||
| 2025-12-11 00:00 |
Annual financial report 2024/2025
|
English | 5.4 MB | ||
| 2025-12-11 00:00 |
Presentation FY 2025
|
English | 962.2 KB | ||
| 2025-12-04 19:10 |
SCHOTT Pharmas preliminary results for fiscal year 2025; outlook for FY 2026 an…
|
English | 8.8 KB | ||
| 2025-12-03 00:00 |
2025 December Declarations of Corporate Governance (german)
|
German | 432.4 KB | ||
| 2025-11-05 18:19 |
SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
|
English | 12.1 KB | ||
| 2025-11-05 17:56 |
SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO
|
English | 4.3 KB | ||
| 2025-11-04 13:18 | English | 12.9 KB | |||
| 2025-10-07 17:00 | English | 4.8 KB |
Automate Your Workflow. Get a real-time feed of all Schott Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Schott Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Schott Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
